Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients & provides custom-made solutions.

Virtual Booth

Contact Supplier

AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

DEVELOPMENTS

29 Drugs in Development

29 Drugs in Development

DIGITAL CONTENT

9 NEWS #PharmaBuzz

media
9 NEWS #PharmaBuzz

Synopsis

ACTIVE PHARMA INGREDIENTS

API Suppliers

USDMF

CEP/COS

JDMF

EU WC

KDMF

NDC API

VMF

Listed Suppliers

API REF. PRICE (USD/KG)

$ 0

MARKET PLACE

API

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

FDF Dossiers

FDA Orange Book

Europe

Canada

Australia

South Africa

Listed Dossiers

29DRUGS IN DEVELOPMENT

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

EDQM

USP

Others

PATENTS & EXCLUSIVITIES

US Patents

US Exclusivities

Health Canada Patents

DIGITAL CONTENT

Data Compilation #PharmaFlow

Stock Recap #PipelineProspector

Weekly News Recap #Phispers

News #PharmaBuzz

GLOBAL SALES INFORMATION

US Medicaid (USD)

Annual Reports (USD Million)

Finished Drug Prices

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown

Click the button for full data set

Also known as: At-007, 2170729-29-8, Govorestat, At007, Govorestat [usan], 6jlq8k35kk

Molecular Formula

C₁₇H₁₀F₃N₃O₃S₂

Molecular Weight

425.4 g/mol

InChI Key

ORQGHAJIWGGFJK-UHFFFAOYSA-N

FDA UNII

6JLQ8K35KK

Gavorestat is under investigation in clinical trial NCT04902781 (Clinical Benefit, Safety, PK and PD Study of AT-007 in Pediatric Subjects With Classic Galactosemia).

1 2D Structure

Govorestat

2 Identification

2.1 Computed Descriptors

2.1.1 IUPAC Name

2-[4-oxo-3-[[5-(trifluoromethyl)-1,3-benzothiazol-2-yl]methyl]thieno[3,4-d]pyridazin-1-yl]acetic acid

2.1.2 InChI

InChI=1S/C17H10F3N3O3S2/c18-17(19,20)8-1-2-13-12(3-8)21-14(28-13)5-23-16(26)10-7-27-6-9(10)11(22-23)4-15(24)25/h1-3,6-7H,4-5H2,(H,24,25)

2.1.3 InChI Key

ORQGHAJIWGGFJK-UHFFFAOYSA-N

2.1.4 Canonical SMILES

C1=CC2=C(C=C1C(F)(F)F)N=C(S2)CN3C(=O)C4=CSC=C4C(=N3)CC(=O)O

2.2 Other Identifiers

2.2.1 UNII

6JLQ8K35KK

2.3 Synonyms

2.3.1 Depositor-Supplied Synonyms

1. At-007

2. 2170729-29-8

3. Govorestat

4. At007

5. Govorestat [usan]

6. 6jlq8k35kk

7. 2-[4-oxo-3-[[5-(trifluoromethyl)-1,3-benzothiazol-2-yl]methyl]thieno[3,4-d]pyridazin-1-yl]acetic Acid

8. Gavorestat

9. Govorestat [inn]

10. Unii-6jlq8k35kk

11. Chembl4650327

12. Schembl19747408

13. Ex-a3180

14. Mfcd32263046

15. Who 11608

16. Zb1621

17. Akos037649079

18. Ac-36354

19. Bs-16512

20. Hy-129586

21. Cs-0106794

22. D81255

23. (4-oxo-3-{[5-(trifluoromethyl)-1,3-benzothiazol-2-yl]methyl}-3,4- Dihydrothieno[3,4-d]pyridazin-1-yl)acetic Acid

24. Thieno[3,4-d]pyridazine-1-acetic Acid, 3,4-dihydro-4-oxo-3-[[5-(trifluoromethyl)-2-benzothiazolyl]methyl]-

2.4 Create Date

2018-01-29

3 Chemical and Physical Properties

Molecular Formula	C₁₇H₁₀F₃N₃O₃S₂
Molecular Weight	425.4 g/mol
XLogP3	3.2
Hydrogen Bond Donor Count	1
Hydrogen Bond Acceptor Count	10
Rotatable Bond Count	4
Exact Mass	425.01156802 g/mol
Monoisotopic Mass	425.01156802 g/mol
Topological Polar Surface Area	139 Å²
Heavy Atom Count	28
Formal Charge	0
Complexity	690
Isotope Atom Count	0
Defined Atom Stereocenter Count	0
Undefined Atom Stereocenter Count	0
Defined Bond Stereocenter Count	0
Undefined Bond Stereocenter Count	0
Covalently Bonded Unit Count	1